Skip to content

Ektachem Clinical Chemistry Slide Glucose (Glu)

by Johnson & Johnson Clinical Diagnostics, Inc.

510(k) K955286

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

2 ongoing

Recall on shared 510(k) K955286; other models may be affected

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK955286 Date17 May 1996ClearedStatusActive

Recalls

7 recalls · 2 ongoing · FDA

  • 2 recalls, same reason

    • Ongoing Z-2560-2025 FDA Class II initiated 29 Jul 2025 on shared 510(k) K955286
    • Ongoing Z-2559-2025 FDA Class II initiated 29 Jul 2025 on shared 510(k) K955286

    VITROS Chemistry Products LAC Slides on VITROS XT 3400 and VITROS XT 7600 Systems are experiencing an increased occurrence of calibration failure related to lots from coating 0130 and above with Condition Code TH4-63J during calibration, causing the delay of lac test results and potentially impact patient management. The issue was identified by QuidelOrtho through an increase in customer complaints compared to the historical baseline with average failure rate of 1% for coating 0130 in 2025 while average of failure rate for other coating was 0.06% in 2025 and average of failure rate for all coatings is 0.03% for 2024.

    • Terminated Z-2202-2019 FDA Class II initiated 17 Jun 2019

    Potentially Biased Results using VITROS Chemistry Products GLU Slides

    • Terminated Z-0090-2017 FDA Class II initiated 11 Aug 2016 on shared 510(k) K955286

    Ortho Clinical Diagnostics confirmed that N-Acetylcysteine (NAC), a drug used for acetaminophen overdose, mucolytic therapy and is used as nutritional supplement, can interfere with VITROS GLU, LAC, TRIG, and URIC Slides assays.

    • Terminated Z-0089-2017 FDA Class II initiated 11 Aug 2016

    Ortho Clinical Diagnostics confirmed that N-Acetylcysteine (NAC), a drug used for acetaminophen overdose, mucolytic therapy and is used as nutritional supplement, can interfere with VITROS GLU, LAC, TRIG, and URIC Slides assays. Ortho also tested several compounds following industry standard CLSI EP7-A2 for potential interference on VITROS GLU Slides during validation testing for a proposed change and confirmed Dextran 40 and Glutathione may interfere with current VITROS GLU Slides.

    • Terminated Z-0314-2014 FDA Class II initiated 12 Jun 2013

    Ortho Clinical Diagnostics is recalling Slide Dispense cartridges used with some VITROS Chemistry Product Slides due to slide dispense issues.

    • Terminated Z-1224-03 FDA Unclassified (pre-2012) initiated 28 Jul 2003

    Results of glucose measurements on sodium fluoride/potassium oxalate specimens can be negatively biased when using Vitros GLU and GLU DT slides stored in the refrigerator. GLU slides are processed by high volume chemistry systems typically used in hospital laboratories.

Recalls on a shared submission name another device cleared under the same FDA submission as this one.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
CGA
Device Class
Class II
Regulation
21 CFR Part 862.1345
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Johnson & Johnson Clinical Diagnostics, Inc.

See all devices from Johnson & Johnson Clinical Diagnostics, Inc. →